Literature DB >> 35301197

Patient-Reported Symptoms and Subsequent Risk of Myocardial Infarction in Chronic Kidney Disease.

Benjamin Lidgard1, Leila R Zelnick2, Kevin D O'Brien2, Nisha Bansal2.   

Abstract

BACKGROUND AND OBJECTIVES: Although patient-reported symptoms often precede acute presentations of cardiovascular disease, patients with nondialysis-requiring CKD are less likely to have typical symptoms of atherosclerotic disease when presenting with acute myocardial infarction. However, the associations between typical atherosclerotic symptoms and subsequent risk of myocardial infarction are unknown in ambulatory patients with CKD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: To determine whether typical atherosclerotic symptoms are associated with risk for subsequent myocardial infarction in people with CKD, we examined participants from the Chronic Renal Insufficiency Cohort Study. Chest pain, shortness of breath, and inability to climb stairs were evaluated annually using the Kidney Disease Quality of Life Instrument. Associations between categorical time-updated symptoms and physician-adjudicated incident myocardial infarction were assessed using Cox regression models.
RESULTS: Among 3910 participants (mean age of 58±11 years; mean eGFR =44±15 ml/min per 1.73 m2), there were 476 incident myocardial infarctions over a median follow-up period of 10.4 years (interquartile range, 5.36-12.6 years). Median time from symptom assessment to incident myocardial infarction was 213 days (interquartile range, 111-333 days). Compared with no symptoms, mild, and moderate or worse, symptoms of chest pain (hazard ratio, 1.30; 95% confidence interval, 1.01 to 1.67; and hazard ratio, 1.70; 95% confidence interval, 1.27 to 2.27, respectively) and shortness of breath (hazard ratio, 1.37; 95% confidence interval, 1.10 to 1.70; and hazard ratio, 1.33; 95% confidence interval, 1.05 to 1.69, respectively) were significantly associated with greater risks for subsequent myocardial infarction. Participants reporting mild and severe limitations in climbing stairs (versus no limitation) had significantly higher adjusted risk of myocardial infarction (hazard ratio, 1.44; 95% confidence interval, 1.10 to 1.89; and hazard ratio, 1.89; 95% confidence interval, 1.44 to 2.49, respectively).
CONCLUSIONS: In a large ambulatory cohort of adults with CKD, symptoms of atherosclerotic cardiovascular disease were strongly associated with a higher risk for subsequent myocardial infarction. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2022_03_17_CJN12080921.mp3.
Copyright © 2022 by the American Society of Nephrology.

Entities:  

Keywords:  cardiovascular disease; chronic kidney disease; myocardial infarction; patient reported outcome measures

Mesh:

Year:  2022        PMID: 35301197      PMCID: PMC8993476          DOI: 10.2215/CJN.12080921

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  46 in total

1.  Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.

Authors:  Guruprasad Manjunath; Hocine Tighiouart; Hassan Ibrahim; Bonnie MacLeod; Deeb N Salem; John L Griffith; Josef Coresh; Andrew S Levey; Mark J Sarnak
Journal:  J Am Coll Cardiol       Date:  2003-01-01       Impact factor: 24.094

2.  The presence of frailty in elderly persons with chronic renal insufficiency.

Authors:  Michael G Shlipak; Catherine Stehman-Breen; Linda F Fried; Xiao Song; David Siscovick; Linda P Fried; Bruce M Psaty; Anne B Newman
Journal:  Am J Kidney Dis       Date:  2004-05       Impact factor: 8.860

Review 3.  Do you know them when you see them? Women's prodromal and acute symptoms of myocardial infarction.

Authors:  J C McSweeney; M Cody; P B Crane
Journal:  J Cardiovasc Nurs       Date:  2001-04       Impact factor: 2.083

4.  Differential symptoms of acute myocardial infarction in patients with kidney disease: a community-wide perspective.

Authors:  Jonathan Sosnov; Darleen Lessard; Robert J Goldberg; Jorge Yarzebski; Joel M Gore
Journal:  Am J Kidney Dis       Date:  2006-03       Impact factor: 8.860

5.  Symptom burden, depression, and quality of life in chronic and end-stage kidney disease.

Authors:  Khaled Abdel-Kader; Mark L Unruh; Steven D Weisbord
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 8.237

6.  Unstable angina pectoris as a warning symptom before acute myocardial infarction.

Authors:  G Kouvaras; G Bacoulas
Journal:  Q J Med       Date:  1987-08

Review 7.  Symptom burden in chronic kidney disease: a review of recent literature.

Authors:  Hayfa Almutary; Ann Bonner; Clint Douglas
Journal:  J Ren Care       Date:  2013-07-04

8.  Symptom burden in patients with chronic kidney disease not requiring renal replacement therapy.

Authors:  Stephanie A Brown; Freya C Tyrer; Amy L Clarke; Laetitia H Lloyd-Davies; Andrew G Stein; Carolyn Tarrant; James O Burton; Alice C Smith
Journal:  Clin Kidney J       Date:  2017-07-10

9.  Determining the research priorities for patients with chronic kidney disease not on dialysis.

Authors:  Brenda R Hemmelgarn; Neesh Pannu; Sofia B Ahmed; Meghan J Elliott; Helen Tam-Tham; Erin Lillie; Sharon E Straus; Maoliosa Donald; Lianne Barnieh; George C Chong; David R Hillier; Kate T Huffman; Andrew C Lei; Berlene V Villanueva; Donna M Young; Elisabeth A Fowler; Braden J Manns; Andreas Laupacis
Journal:  Nephrol Dial Transplant       Date:  2017-05-01       Impact factor: 5.992

Review 10.  Patient-Reported Outcomes in Patients with Chronic Kidney Disease and Kidney Transplant-Part 1.

Authors:  Evan Tang; Aarushi Bansal; Marta Novak; Istvan Mucsi
Journal:  Front Med (Lausanne)       Date:  2018-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.